menu ☰
menu ˟

High-dose cyclophosphamide may reduce severe GVHD after HSCT

01 Mar 2016
Treatment with high-dose cyclophosphamide appeared associated with lower rates of severe graft-versus-host disease, improved transplant-related mortality, and decreased admissions and inpatient hospital stays among patients undergoing hematopoietic s...

Click here to view the full article which appeared in Hematology Oncology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.